CONTIPHARMA: what changed
What changed
CONTIPHARMA
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€1.1m
2024 · -€151,785+€1.2m
Equity
€3.2m
2024 · €2.2m+€1.1m
Cash
€705,529
2024 · €611,264+€94,265
Balance sheet total
€7.2m
2024 · €7.2m+€30,127
Largest movements
Assets
- Financial fixed assets -€1.4m
down €1.4m (-27.8%), from €5.0m to €3.6m
- Receivables within one year +€1.2m
up €1.2m (+103%), from €1.2m to €2.4m
of which Other amounts receivable: +€2.2m
- Cash +€94,265
up €94,265 (+15.4%), from €611,264 to €705,529
mainly Investment in fixed assets (net) (+€1.3m) and Net result for the year (+€1.1m)
- Tangible fixed assets +€72,279
up €72,279 (+182%), from €39,629 to €111,908
Equity and liabilities
- Profit (loss) carried forward +€1.1m
up €1.1m (+1,568%), from €68,082 to €1.1m
- Short-term financial debts -€1.0m
down €1.0m (-100%), from €1.0m to €0
- Debts after one year -€333,510
down €333,510 (-11.9%), from €2.8m to €2.5m
of which Financial debts: -€333,510
- Trade debts +€248,539
up €248,539 (+33.8%), from €734,516 to €983,055
Income statement
- Gross operating margin +€2.8m
up €2.8m, from -€95,623 to €2.7m
- Financial charges +€1.5m
up €1.5m (+6,476%), from €23,068 to €1.5m
of which Non-recurring financial charges: +€1.4m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€151,785
Gross operating margin
+€2.8m
Staff costs
-€26,123
Depreciation
-€11,146
Other operating charges
-€4,810
Financial income
-€9,096
Financial charges
-€1.5m
Taxes
-€8,702
Result 2025
€1.1m
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€97,032
Investment
+€1.3m
Financing
-€1.3m
Cash 2024
€611,264
From operations (derived)
+€97,032
Net result for the year
+€1.1m
Depreciation
+€15,884
Receivables within one year
-€1.2m
Deferred charges and accrued income
-€42,191
Trade debts
+€248,539
Tax, wage and social debts
+€16,134
Other debts
+€1,815
Accrued charges and deferred income
+€14,400
Investment (derived)
+€1.3m
Investment in fixed assets (net)
+€1.3m
Financing
-€1.3m
Debts after one year
-€333,510
Current portion of long-term debt
+€14,986
Short-term financial debts
-€1.0m
Cash 2025
€705,529
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,182,396 | €7,212,523 | +€30,127 | +0.4% |
| Fixed assets | 21/28 | €5,081,789 | €3,750,148 | -€1.3m | -26.2% |
| Intangible fixed assets | 21 | €9,021 | €5,101 | -€3,920 | -43.5% |
| Tangible fixed assets | 22/27 | €39,629 | €111,908 | +€72,279 | +182% |
| Furniture and vehicles | 24 | €39,629 | €111,908 | +€72,279 | +182% |
| Financial fixed assets | 28 | €5,033,139 | €3,633,139 | -€1.4m | -27.8% |
| Current assets | 29/58 | €2,100,607 | €3,462,375 | +€1.4m | +64.8% |
| Amounts receivable within one year | 40/41 | €1,189,072 | €2,414,384 | +€1.2m | +103% |
| Trade receivables | 40 | €1,000,000 | €7,301 | -€992,699 | -99.3% |
| Other amounts receivable | 41 | €189,072 | €2,407,082 | +€2.2m | +1,173% |
| Cash at bank and in hand | 54/58 | €611,264 | €705,529 | +€94,265 | +15.4% |
| Deferred charges and accrued income | 490/1 | €300,271 | €342,462 | +€42,191 | +14.1% |
| Total equity and liabilities | 10/49 | €7,182,396 | €7,212,523 | +€30,127 | +0.4% |
| Equity | 10/15 | €2,166,783 | €3,234,545 | +€1.1m | +49.3% |
| Contributions | 10/11 | €1,907,910 | €1,907,910 | = | 0.0% |
| Capital | 10 | €1,907,910 | €1,907,910 | = | 0.0% |
| Issued capital | 100 | €1,907,910 | €1,907,910 | = | 0.0% |
| Reserves | 13 | €190,791 | €190,791 | = | 0.0% |
| Non-distributable reserves | 130/1 | €190,791 | €190,791 | = | 0.0% |
| Legal reserve | 130 | €190,791 | €190,791 | = | 0.0% |
| Profit (loss) carried forward | 14 | €68,082 | €1,135,844 | +€1.1m | +1,568% |
| Amounts payable | 17/49 | €5,015,613 | €3,977,978 | -€1.0m | -20.7% |
| Amounts payable after more than one year | 17 | €2,812,304 | €2,478,794 | -€333,510 | -11.9% |
| Financial debts | 170/4 | €412,304 | €78,794 | -€333,510 | -80.9% |
| Other amounts payable | 178/9 | €2,400,000 | €2,400,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €1,754,393 | €1,035,868 | -€718,526 | -41.0% |
| Current portion of amounts payable after more than one year | 42 | €8,444 | €23,430 | +€14,986 | +177% |
| Financial debts | 43 | €1,000,000 | €0 | -€1.0m | -100% |
| Credit institutions | 430/8 | €1,000,000 | €0 | -€1.0m | -100% |
| Trade debts | 44 | €734,516 | €983,055 | +€248,539 | +33.8% |
| Suppliers | 440/4 | €734,516 | €983,055 | +€248,539 | +33.8% |
| Taxes, remuneration and social security | 45 | €10,059 | €26,193 | +€16,134 | +160% |
| Taxes | 450/3 | €122 | €8,824 | +€8,702 | +7,112% |
| Remuneration and social security | 454/9 | €9,936 | €17,368 | +€7,432 | +74.8% |
| Other amounts payable | 47/48 | €1,375 | €3,190 | +€1,815 | +132% |
| Accrued charges and deferred income | 492/3 | €448,915 | €463,315 | +€14,400 | +3.2% |
| Remuneration, social security and pensions | 62 | €78,937 | €105,060 | +€26,123 | +33.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,738 | €15,884 | +€11,146 | +235% |
| Other operating charges | 640/8 | €335 | €5,146 | +€4,810 | +1,434% |
| Gross operating margin | 9900 | -€95,623 | €2,677,653 | +€2.8m | |
| Operating profit (loss) | 9901 | -€179,633 | €2,551,564 | +€2.7m | |
| Financial income | 75/76B | €51,039 | €41,943 | -€9,096 | -17.8% |
| Recurring financial income | 75 | €51,039 | €41,943 | -€9,096 | -17.8% |
| Financial charges | 65/66B | €23,068 | €1,516,920 | +€1.5m | +6,476% |
| Recurring financial charges | 65 | €23,068 | €116,920 | +€93,852 | +407% |
| Non-recurring financial charges | 66B | - | €1,400,000 | +€1.4m | |
| Profit (loss) for the period before taxes | 9903 | -€151,662 | €1,076,587 | +€1.2m | |
| Income taxes | 67/77 | €122 | €8,824 | +€8,702 | +7,112% |
| Profit (loss) for the period | 9904 | -€151,785 | €1,067,762 | +€1.2m | |
| Profit (loss) for the period to be appropriated | 9905 | -€151,785 | €1,067,762 | +€1.2m |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.